On the recordJuly 19, 2011
Do you believe that the clinical trial standards laid out by FDA in the premarket approval process are rigorous enough to prove safety and effectiveness of class III devices?
Source
congress.govJohn Dingell: “Do you believe that the clinical trial standards laid out by FDA in the premarket approval process are rigorous enough…”
Editor's note · Context
Dingell questions the adequacy of FDA's clinical trial standards for class III devices.
Share
More from John Dingell
May 6, 2014
As of today, as I said, more than 8 million people enrolled in private plans through Federal and State marketplaces.
May 6, 2014
I raise this issue today because the NRC will soon be considering a proposal to dispose of this waste in a nearby mill site.
Other voices in this conversation
